Voyager Therapeutics (VYGR) Competitors

Gyre Therapeutics (NASDAQ:GYRE) and Voyager Therapeutics (NASDAQ:VYGR) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, profitability, analyst recommendations, community ranking, dividends, media sentiment, risk, valuation and institutional ownership.

Which has higher valuation and earnings, GYRE or VYGR?

Voyager Therapeutics has lower revenue, but higher earnings than Gyre Therapeutics. Voyager Therapeutics is trading at a lower price-to-earnings ratio than Gyre Therapeutics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Gyre Therapeutics	$100.64M	7.52	-$92.93M	$0.02	403.50
Voyager Therapeutics	$66.96M	2.98	$132.33M	-$1.46	-2.47

Does the media favor GYRE or VYGR?

In the previous week, Voyager Therapeutics had 10 more articles in the media than Gyre Therapeutics. MarketBeat recorded 16 mentions for Voyager Therapeutics and 6 mentions for Gyre Therapeutics. Voyager Therapeutics' average media sentiment score of 0.65 beat Gyre Therapeutics' score of 0.60 indicating that Voyager Therapeutics is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Gyre Therapeutics	0 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Voyager Therapeutics	2 Very Positive mention(s)	5 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Does the MarketBeat Community believe in GYRE or VYGR?

Voyager Therapeutics received 400 more outperform votes than Gyre Therapeutics when rated by MarketBeat users. However, 100.00% of users gave Gyre Therapeutics an outperform vote while only 67.74% of users gave Voyager Therapeutics an outperform vote.

Company	Underperform	Outperform
Gyre Therapeutics	Outperform Votes 1 100.00%	Underperform Votes No Votes
Voyager Therapeutics	Outperform Votes 401 67.74%	Underperform Votes 191 32.26%

Do analysts recommend GYRE or VYGR?

Voyager Therapeutics has a consensus price target of $13.39, suggesting a potential upside of 271.94%. Given Voyager Therapeutics' stronger consensus rating and higher possible upside, analysts clearly believe Voyager Therapeutics is more favorable than Gyre Therapeutics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Gyre Therapeutics	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
Voyager Therapeutics	0 Sell rating(s)	0 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	3.13

Do institutionals & insiders believe in GYRE or VYGR?

24.0% of Gyre Therapeutics shares are held by institutional investors. Comparatively, 48.0% of Voyager Therapeutics shares are held by institutional investors. 10.0% of Gyre Therapeutics shares are held by company insiders. Comparatively, 6.4% of Voyager Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Is GYRE or VYGR more profitable?

Voyager Therapeutics has a net margin of 15.80% compared to Gyre Therapeutics' net margin of -84.57%. Voyager Therapeutics' return on equity of 8.33% beat Gyre Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Gyre Therapeutics	-84.57%	-118.43%	-71.97%
Voyager Therapeutics	15.80%	8.33%	6.15%

Which has more risk and volatility, GYRE or VYGR?

Gyre Therapeutics has a beta of 1.79, suggesting that its share price is 79% more volatile than the S&P 500. Comparatively, Voyager Therapeutics has a beta of 0.82, suggesting that its share price is 18% less volatile than the S&P 500.

Summary

Voyager Therapeutics beats Gyre Therapeutics on 12 of the 19 factors compared between the two stocks.